IGM Cash from 2010 to 2024

IGMS Stock  USD 9.40  0.51  5.74%   
IGM Biosciences Cash yearly trend continues to be comparatively stable with very little volatility. Cash will likely drop to about 101.6 M in 2024. Cash is the total amount of money in the form of currency that IGM Biosciences has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2018-03-31
Previous Quarter
67.3 M
Current Value
42.9 M
Quarterly Volatility
79 M
 
Covid
Check IGM Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IGM Biosciences' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 8.7 M or Interest Expense of 8.3 M, as well as many indicators such as Price To Sales Ratio of 194, Dividend Yield of 0.0 or PTB Ratio of 2.25. IGM financial statements analysis is a perfect complement when working with IGM Biosciences Valuation or Volatility modules.
  
Check out the analysis of IGM Biosciences Correlation against competitors.
For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

Latest IGM Biosciences' Cash Growth Pattern

Below is the plot of the Cash of IGM Biosciences over the last few years. Cash refers to the most liquid asset of IGM Biosciences, which is listed under current asset account on IGM Biosciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from IGM Biosciences customers. The amounts must be unrestricted with restricted cash listed in a different IGM Biosciences account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. IGM Biosciences' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IGM Biosciences' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

IGM Cash Regression Statistics

Arithmetic Mean50,064,814
Geometric Mean4,340,670
Coefficient Of Variation148.39
Mean Deviation61,255,219
Median432,000
Standard Deviation74,291,068
Sample Variance5519.2T
Range240.6M
R-Value0.71
Mean Square Error2933T
R-Squared0.51
Significance0
Slope11,822,988
Total Sum of Squares77268.3T

IGM Cash History

2024101.6 M
2023112.5 M
2022121.2 M
2021133.3 M
2020241.1 M
201935.9 M
20181.9 M

Other Fundumenentals of IGM Biosciences

IGM Biosciences Cash component correlations

About IGM Biosciences Financial Statements

IGM Biosciences shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although IGM Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in IGM Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on IGM Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IGM Stock Analysis

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.